A Study of LY3971297 in Healthy Participants

NCT06148272 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

225

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Obesity
Hypertension

Interventions

DRUG: LY3971297
DRUG: Placebo
DRUG: LY3971297 IV

Sponsor

Eli Lilly and Company